News

News

Press Release | KBI Biopharma Expands US Operations With New $150 Million Commercial Manufacturing Facility Based In RTP, North Carolina

Learn More
News

Press Release | JSR Life Sciences Expands Its European Gene-to-GMP Biologics Manufacturing Facilities For Selexis And KBI Biopharma In Geneva, Switzerland

Learn More
News

Press Release | JSR Life Sciences Company KBI Biopharma, Inc. Promotes Dirk Lange to CEO

Learn More
News

Press Release | AbSci Closes $15.4 M in Series D Funding to Accelerate Growth and Scale Disruptive Protein PrintingTM Technology, Announces Exclusive Co-Marketing Partnership with KBI Biopharma

Learn More
News

Press Release | ZyVersa Therapeutics to Advance Development of Its Lead Inflammasome Inhibitor with Selexis and KBI Biopharma’s Integrated Development Platform

Learn More
News

Press Release | KBI Biopharma Inc. and Selexis SA Form Joint Scientific Advisory Board

Learn More
News

Press Release | CytoSen Therapeutics and KBI Biopharma Enter into Strategic Partnership to Manufacture NK Cells and Nanoparticles

Learn More
News

KBI in the News | KBI boosts analytical services with Belgium expansion - via BioProcess International

Learn More
News

Press Release | KBI Biopharma BVBA Opens in Leuven, Belgium, Offering Analytical Services to the European Market

Learn More
News

KBI in the News | AdAlta secures key manufacturing agreements for AD-214

Learn More
Page 1 of 6